Join Dr Moraitis and get an understanding of the regulatory requirements and design considerations for radiopharmaceutical treatments, particularly those involving beta emitters like ¹⁷⁷Lu-PSMA radioligand therapy. He highlights the differences in inpatient and outpatient settings across countries, the bi-exponential clearance of radioligand therapy, the importance of maintaining dose rates below specific thresholds, and the need for comprehensive documentation and regulatory approvals. He also details the setup of treatment rooms to ensure radiation safety, including the use of individual bathrooms connected to waste tanks to manage radioactive waste effectively. Finally, Dr Moraitis emphasizes the importance of radiation safety certificates for personnel and the sequential use of rooms for different treatments to minimize contamination risks.